28 related articles for article (PubMed ID: 1977066)
1. Augmentation of ventral tegmental area stimulation-induced feeding by both stimulation and lesion of the contralateral ventral tegmental area in the rat.
Maliszewska-Scisło M; Trojniar W
Acta Neurobiol Exp (Wars); 1999; 59(4):287-93. PubMed ID: 10645633
[TBL] [Abstract][Full Text] [Related]
2. Classics in Chemical Neuroscience: Aripiprazole.
Casey AB; Canal CE
ACS Chem Neurosci; 2017 Jun; 8(6):1135-1146. PubMed ID: 28368577
[TBL] [Abstract][Full Text] [Related]
3. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
Momiyama T; Todo N; Sasa M
Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
Momiyama T; Sasa M; Takaori S
Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
Mantz J; Godbout R; Pirot S; Glowinski J; Thierry AM
Neurochem Int; 1992 Mar; 20 Suppl():251S-254S. PubMed ID: 1365436
[No Abstract] [Full Text] [Related]
6. Dopaminergic drugs in the cationic form interact with D2 dopamine receptors.
Miller DD; Harrold M; Wallace RA; Wallace LJ; Uretsky NJ
Trends Pharmacol Sci; 1988 Aug; 9(8):282-4. PubMed ID: 2907954
[No Abstract] [Full Text] [Related]
7. Inhibition by talipexole, a thiazolo-azepine derivative, of dopaminergic neurons in the ventral tegmental area.
Momiyama T; Sasa M; Takaori S
Life Sci; 1991; 49(7):535-43. PubMed ID: 1677740
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.
Momiyama T; Amano T; Todo N; Sasa M
Eur J Pharmacol; 1996 Aug; 310(1):1-8. PubMed ID: 8880060
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic inhibition of excitatory input from the substantia nigra to caudate nucleus neurons by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392).
Sasa M; Ohno Y; Takaori S
Life Sci; 1988; 43(3):263-9. PubMed ID: 3398698
[TBL] [Abstract][Full Text] [Related]
10. Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens.
Amano T; Matsubayashi H; Momiyama T; Ishihara K; Todo N; Sasa M
Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):105-16. PubMed ID: 7708924
[TBL] [Abstract][Full Text] [Related]
11. Ventral tegmental area-mediated inhibition of neurons of the nucleus accumbens receiving input from the parafascicular nucleus of the thalamus is mediated by dopamine D1 receptors.
Hara M; Sasa M; Takaori S
Neuropharmacology; 1989 Nov; 28(11):1203-9. PubMed ID: 2687713
[TBL] [Abstract][Full Text] [Related]
12. D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area.
Momiyama T; Sasa M; Takaori S
Life Sci; 1990; 47(9):761-9. PubMed ID: 1977066
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
